BIM
ACER

BlackRock Investment Management’s Acer Therapeutics Inc ACER Stock Holding History

BlackRock Investment Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-56
Closed -$3K – 4216
2015
Q1 		$3K Hold
56
– – ﹤0.01% 3950
2014
Q4 		$3K Hold
56
– – ﹤0.01% 4015
2014
Q3 		$5K Hold
56
– – ﹤0.01% 3903
2014
Q2 		$8K Buy
+56
New +$7.41K ﹤0.01% 3730

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BlackRock Investment Management's ACER Position: Q2 2015 in Review

BlackRock Investment Management sold out of Acer Therapeutics Inc (ACER) in Q2 2015, closing a stake of 56 shares — an estimated $3K sold.

BlackRock Investment Management first reported a position in ACER in Q2 2014 and held it in 4 quarters. The position peaked at $8K in Q2 2014. 16 funds tracked by Wall St. Rank hold ACER as of Q2 2015.

  • BlackRock Investment Management reported no remaining Acer Therapeutics Inc position as of Q2 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 56 Acer Therapeutics Inc shares in Q2 2015, an estimated $3K.
  • BlackRock Investment Management first reported a position in Acer Therapeutics Inc in Q2 2014 and held it in 4 quarters.
  • BlackRock Investment Management's Acer Therapeutics Inc position peaked at $8K in Q2 2014.
  • 16 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.